PACS vs DVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

PACS

71.8
AI Score
VS
PACS Wins

DVA

51.0
AI Score

Investment Advisor Scores

PACS

72score
Recommendation
BUY

DVA

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PACS DVA Winner
Forward P/E 16.0772 9.99 DVA
PEG Ratio 1.0712 0.4502 DVA
Revenue Growth 9.1% 5.2% PACS
Earnings Growth 51.6% 55.8% DVA
Tradestie Score 71.8/100 51.0/100 PACS
Profit Margin 4.9% 6.0% DVA
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD PACS

Relative Price Performance (Last 90 Days)

PACS 1M: -1.6% · 3M: +28.8% DVA 1M: +0.0% · 3M: -10.9%

Current Technical Phase

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.5 · Price: $44.76

DVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.3%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $181.55

Fundamentals Snapshot

Metric PACS DVA
Market Cap
Forward P/E 16.5 10.5
Trailing P/E 26.1 15.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.2%
EPS 1.72 11.70
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.